Toyota, Suzuki to work together in green, safety technology
Japanese automakers Toyota and Suzuki, which began looking into a partnership in October, say they have decided to work together in ecological and safety technology — a rapidly growing area in the industry.
Diet Companies See an Uptick With Men After Super Bowl
Forget New Year’s Day, the new diet start date—for men —is the day after the Super Bowl, according to big diet companies.
Trump Extends Timetable to Replace Obamacare
President Donald Trump downgraded expectations for his party's swift repeal and replacement of the 2010 health law in a Sunday interview with Fox News' Bill O'Reilly, saying "maybe it'll take til some time into next year"
Belarus threatens to prosecute Russian food safety official
Belarusian President Alexander Lukashenko in a televised outburst has asked the country's interior minister to press charges against Russia's top food safety official.
Prosecutors: Woman used dirt to contaminate chicken at plant
A woman is facing charges for allegedly using dirt to contaminate chicken while working at a Minnesota processing plant.
Recalls this week: Dressers, chairs, power adapters
Several lines of dressers are being recalled because they pose a tip-over hazard.
Nissan recalls Altima; door may open if window rolled down
You might not want to open a rear window if you're driving a Nissan Altima.
Metal objects in some cans prompt Skoal tobacco recall
Some varieties of Skoal, Copenhagen, Cope and Husky brand smokeless tobacco are being voluntarily recalled amid complaints of metal objects, some of them sharp, being spotted in cans.
Merck's 4Q Revenue Falls Short
Merck's quarterly revenue narrowly missed Wall Street expectations, hurt by lower-than-expected sales of its key immuno-oncology drug, Keytruda, and its diabetes medicines.
Merck scores a hit with Keytruda, watches spending in 4Q
Merck & Co.'s new cancer medicine Keytruda, a blockbuster nearly overnight, along with aggressive and ongoing cost cuts, helped to boost fourth-quarter profits by 21 percent.
Cigna's Profit Beats Estimates
Cigna, which is awaiting a ruling on the U.S. government's lawsuit to block its acquisition by Anthem, reported a better-than-expected quarterly profit, helped by strength in its commercial business.
Companies Turn Red To Help Fight This Deadly Disease
Every minute, a woman dies from heart disease in the United States – and many of them never see it coming, which the American Heart Association (AHA) says could make a life-saving difference.
AstraZeneca says fourth-quarter revenue fell 13 percent
Anglo-Swedish drugmaker AstraZeneca says fourth-quarter revenue fell 13 percent after the cholesterol treatment Crestor lost patent protection in the United States.
What’s delaying the GOP from repealing Obamacare?
President Trump vs. Democrats
Self-driving car prototypes need less human help, data show
Self-driving car prototypes appear to be getting better at negotiating California streets and highways without a human backup driver intervening, according to data made public Wednesday by California transportation regulators.
Insurers shrink from exchanges as lawmakers mull changes
The Affordable Care Act's insurance exchanges have become too risky for major health insurers, and that's creating further doubt about coverage options consumers might have next year.
Entrepreneurs: Health law changes may mean finding new jobs
Stay in business for yourself or go back to working for someone else? That's the choice some small business owners and freelancers are worried they may have to make, depending on what changes Congress makes in the health care law.
Big Pharma CEO Says Insurers Will 'Ultimately Determine How Much Patients Pay'
Along with making U.S. job growth a priority, President Trump has also called on the pharmaceutical industry to rein in drug prices. PhRMA CEO Steve Ubl appeared on the FOX Business Network to discuss a meeting that took place between the President and pharmaceutical industry executives early Tuesday.
Phrma CEO: Insurers ultimately decide how much patients pay out of pocket
Phrma CEO Steve Ubl on Trump meeting
Eli Lilly CEO Optimistic Trump Policies Can Boost Pharma Operations, Jobs in U.S.
President Trump met with pharmaceutical industry CEOs Tuesday to discuss a host of topics from drug prices and U.S. manufacturing to the administration’s economic policies. Eli Lilly CEO David A. Ricks discussed the outcome of the meeting.















